Cellscript, LLC
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
7
Ending by 2030
Apr 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 14, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,846,348 | Kits and methods for generating 5′ capped RNA In force · From the USPTO record | In force | From the USPTO record | |
| US 9,005,930 | Kits and Methods for Generating 5' Capped RNA In force · Medium confidence | In force | Medium confidence | |
| US 9,115,380 | Kits and methods for generating 5′ capped RNA In force · From the USPTO record | In force | From the USPTO record | |
| US 8,304,183 | Selective terminal tagging of nucleic acids In force · From the USPTO record | In force | From the USPTO record | |
| US 8,329,887 | Synthesis of tagged nucleic acids In force · From the USPTO record | In force | From the USPTO record | |
| US 8,039,214 | Synthesis of tagged nucleic acids In force · From the USPTO record | In force | From the USPTO record | |
| US 11,028,370 | RNA Preparations Comprising Purified Modified RNA for Reprogramming Cells In force · Low confidence | In force | Low confidence | |
| US 9,862,926 | Inhibition of innate immune response In force · From the USPTO record | In force | From the USPTO record | |
| US 10,793,831 | Inhibition of innate immune response In force · From the USPTO record | In force | From the USPTO record | |
| US 11,135,314 | MAKING AND USING IN VITRO-SYNTHESIZED ssRNA FOR INTRODUCING INTO MAMMALIAN CELLS TO INDUCE A BIOLOGICAL OR BIOCHEMICAL EFFECT In force · Low confidence | In force | Low confidence |
Also on record, not counted in the 12: 3 patents in force now held by others · 2 lapsed for an unpaid fee · 2 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 2 abandoned · 2 no status recorded
Showing 1 to 5 of 5, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/802,601 | MAKING AND USING IN VITRO SYNTHESIZED ssRNA FOR INTRODUCING INTO MAMMALIAN CELLS TO INDUCE A BIOLOGICAL OR BIOCHEMICAL EFFECT | Aug 13, 2024 | Pending |
| 17/998,752 | Compositions, Systems, and Methods for Generating Gene-Edited Cells | May 17, 2021 | Abandoned |
| 17/034,999 | Sep 28, 2020 | No status recorded | |
| 16/968,792 | Treatment of Infections and Immune Dysregulation in Patients with Primary Immune Deficiencies Using Mrna-Corrected Autologous Granulocytes, Lymphocytes And/Or Natural Killer Cells | Feb 19, 2019 | Abandoned |
| 13/731,802 | Dec 31, 2012 | No status recorded |